Results of Jiwa Bio-Pharm Holdings (HKG:2327) for the fiscal year ended 31 March 2012:
Net profit: HK$70.62M, down 72.38% YoY EPS: HK 4.39 cents Final dividend: HK 2.1 cents
Source:chinesestock.org